Anna Keating
Family · Port Royal, SCNPI 1194407916
Payments from drug & device makers
Across 156 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$443
- Acadia Pharmaceuticals Inc$346
- Teva Pharmaceuticals USA, Inc.$334
- AbbVie$331
- Argenx US, Inc.$314
- Eisai Inc.$309
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,773100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 19 | $443 |
| Acadia Pharmaceuticals Inc | 12 | $346 |
| Teva Pharmaceuticals USA, Inc. | 15 | $334 |
| AbbVie | 16 | $331 |
| Argenx US, Inc. | 10 | $314 |
| Eisai Inc. | 16 | $309 |
| AstraZeneca(2 entities) | 10 | $246 |
| UCB, Inc. | 5 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $139 |
| Genentech USA, Inc. | 5 | $138 |
| TG Therapeutics, Inc. | 6 | $133 |
| Amneal Pharmaceuticals LLC | 8 | $129 |
| Lilly USA, LLC | 6 | $129 |
| Neurocrine Biosciences, Inc. | 4 | $84 |
| Biogen | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| EMD Serono, Inc. | 2 | $58 |
| Pfizer | 2 | $57 |
| Tanabe Pharma America, Inc. | 2 | $47 |
| Harmony Biosciences LLC | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| SK Life Science, Inc. | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Novartis | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$125
How this compares
$3,773 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 62 | $1,630 |
| Oxcarbazepine | 24 | $1,355 |
| Propranolol Hcl ErPropranolol Hcl | 16 | $1,139 |
| Carbamazepine ErCarbamazepine | 12 | $973 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 43 | $855 |
| Primidone | 26 | $698 |
| Memantine Hcl | 19 | $616 |
| Topiramate | 26 | $403 |
| Gabapentin | 49 | $344 |
| Propranolol Hcl | 17 | $294 |
| Donepezil Hcl | 31 | $245 |
Paid to pharmacies, not to this prescriber.
Other family in Port Royal
- Alison FogartyGreenville$2M
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
- Doris ReidSimpsonville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.